Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1396, 2003-01, pp. : 20-20
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Tysabri label update: liver injury
Reactions Weekly, Vol. 1, Iss. 1192, 2008-01 ,pp. :
Access to resources
Recommend
Tysabri label update: liver injury
Inpharma, Vol. 1, Iss. 1628, 2008-01 ,pp. :
Psoriasis and Vascular Risk: An Update
Current Pharmaceutical Design, Vol. 20, Iss. 39, 2014-12 ,pp. :
Canadian Permax label change: risk of cardiac valvulopathy
Reactions Weekly, Vol. 1, Iss. 1026, 2004-01 ,pp. :
Citalopram label recognises need for use in some at-risk patients
Reactions Weekly, Vol. 1, Iss. 1396, 2012-01 ,pp. :